|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 06-16 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 06-16 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 132M 122M 113M 213M 14.5B 217M 1.45B 568M 7.2B 570M 558M 24.21B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 112M 104M 95.74M 180M 12.29B 184M 1.23B 481M 6.1B 483M 473M 20.52B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 3 months | +30.19% | ||
| 6 months | +100.34% | ||
| Current year | +159.10% |
| Current year | 9.11 |  | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 86.7 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Punit Patel
BRD | Director/Board Member | - | 15/06/2026 |
Ravi Yadavar
BRD | Director/Board Member | 26 | 15/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/05/26 | Free | Director | 4,851 | 0.0753% | ||
| 02/03/26 | Free | Chief Financial Officer | 39,932 | 0.6223% | ||
| 21/02/26 | Fiscal year | Chairperson | 2,852 | 0.0444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +120.44% | -72.42% | 152M | |
| -3.83% | -1.91% | +53.04% | +155.90% | 1,079B | |
| -3.56% | -1.22% | +53.11% | +52.87% | 640B | |
| -1.54% | +0.86% | +36.88% | +73.24% | 465B | |
| -2.29% | +1.12% | +36.13% | +30.60% | 353B | |
| -2.28% | -0.69% | +33.42% | +39.21% | 301B | |
| -3.15% | +0.25% | +10.63% | +13.71% | 271B | |
| -2.12% | +3.31% | +1.82% | -39.41% | 228B | |
| -0.17% | +3.93% | +28.11% | +64.89% | 209B | |
| -1.76% | -0.30% | +13.69% | +71.36% | 165B | |
| Average | -2.07% | +4.38% | +38.73% | +38.99% | 370.98B | |
| Weighted average by Cap. | -2.78% | +4.86% | +38.44% | +75.14% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 347K 323K 298K 560K 38.19M 571K 3.82M 1.5M 18.97M 1.5M 1.47M 63.78M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
